The study investigates the long-term administration of alpha-interferon and lamivudine in patients with chronic Hepatitis B, focusing on their efficacy and safety. This research includes a comprehensive analysis of treatment outcomes, side effects, and patient quality of life. Evidence from clinical observations suggests that alpha-interferon combined with lamivudine demonstrates significant antiviral effects, reducing viral load and improving liver function in patients over extended periods. The findings advocate for this combination therapy as a viable option in managing chronic Hepatitis B, balancing its benefits against potential adverse effects.
Jaboli, F.m., Roda, E., Fabbri, C., Marchetto, S., Azzaroli, F., Nigro, G., et al. (2001). The efficacy and safety of long-term administration of alpha-interferon and lamivudine in patients with chronic hepatitis B. GASTROENTEROLOGY, 120(5), A572-A572.
The efficacy and safety of long-term administration of alpha-interferon and lamivudine in patients with chronic hepatitis B
Fabbri, C;Azzaroli, F;Mazzella, G
2001
Abstract
The study investigates the long-term administration of alpha-interferon and lamivudine in patients with chronic Hepatitis B, focusing on their efficacy and safety. This research includes a comprehensive analysis of treatment outcomes, side effects, and patient quality of life. Evidence from clinical observations suggests that alpha-interferon combined with lamivudine demonstrates significant antiviral effects, reducing viral load and improving liver function in patients over extended periods. The findings advocate for this combination therapy as a viable option in managing chronic Hepatitis B, balancing its benefits against potential adverse effects.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
